EUVIMEDOdkrijte EUVIMED
Crossref

The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats

S Tokuyama, H Zhu, H Wakabayashi, Y Z Feng, I K Ho

Journal of Biomedical Science · 1998-01 · 5 (1) · 45-53

DOI: 10.1007/bf02253355 ↗

At a glance

Journal article in Journal of Biomedical Science, 1998-01. Written by S Tokuyama and 4 co-authors. Institution: Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216-4505, USA. Cited 25 times so far (Crossref); 38 references. Funded by: NIDA NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

To investigate the role of glutamate in the locus coeruleus (LC) during opioid withdrawal, rats were continuously infused with morphine (a mu-opioid receptor agonist, 26 nmol/microl/h) or butorphanol (a mu/delta/kappa-mixed opioid receptor agonist, 26 nmol/microl/h) intracerebroventricularly (i.c.v.) via osmotic minipumps for 3 days. A direct LC injection of glutamate (1 or 10 nmol/5 microl) or naloxone (an opioid receptor antagonist, 24 nmol/5 microl) induced withdrawal signs in morphine- or butorphanol-dependent animals. However, these agents failed to precipitate any withdrawal signs in saline-treated control animals. On the other hand, the expression of withdrawal signs precipitated by the administration of glutamate or naloxone in opioid-dependent animals was completely blocked by concomitant infusion with 1 or 10 nmol/microl/h of an inhibitor of adenosine 3',5'-cyclic monophosphate (cAMP)-dependent protein kinase and protein kinase C, H-7 [1-(5-isoquinolinesulfonyl)-2-methylpiperazine]. In animals that had been infused with opioids in the same manner, i.c.v. injection of naloxone (48 nmol/5 microl) precipitated withdrawal signs and increased extracellular fluid levels of glutamate in the LC of morphine- or butorphanol-dependent rats measured by in vivo microdialysis method. However, concomitant infusion with H-7 inhibited the increases of glutamate levels in the LC. These results strongly suggest that an expeditious release of glutamate in the LC region plays an important role in the expression of physical dependence on opioids. Furthermore, the action on glutamate release might be increased by the enhancement of cAMP-dependent protein kinase and/or protein kinase C activity.

Subjects

MeSH terms (MEDLINE)

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAnimalsButorphanolGlutamic AcidInfusions, ParenteralLocus CoeruleusMaleMicrodialysisMorphine DependenceMotor ActivityNaloxoneProtein Kinase InhibitorsRatsRats, Sprague-DawleySubstance Withdrawal SyndromeSubstance-Related Disorders

Substances

Protein Kinase InhibitorsNaloxoneGlutamic Acid1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineButorphanol

Authors and institutions

  • Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216-4505, USA.

Funding

  • NIDA NIH HHS

Cite

APA

Tokuyama, S., Zhu, H., Wakabayashi, H., Feng, Y. Z., & Ho, I. K. (1998). The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. Journal of Biomedical Science, 5(1), 45-53. https://doi.org/10.1007/bf02253355

Vancouver

Tokuyama S, Zhu H, Wakabayashi H, Feng YZ, Ho IK. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. Journal of Biomedical Science. 1998;5(1):45-53. doi:10.1007/bf02253355

BibTeX
@article{Tokuyama1998,
  author = {Tokuyama, S and Zhu, H and Wakabayashi, H and Feng, Y Z and Ho, I K},
  title = {The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats},
  journal = {Journal of Biomedical Science},
  year = {1998},
  volume = {5},
  number = {1},
  pages = {45--53},
  doi = {10.1007/bf02253355}
}
Start for free →